| Reshma Kewalramani |
CEO & President, Director |
$45.2M |
+$3.9M |
+9.43% |
Aug 6, 2025 |
| Amit Sachdev |
EVP Chief Patient & Ext Af Off |
$33.3M |
|
|
Feb 26, 2025 |
| Stuart A. Arbuckle |
Evp, Coo |
$28.6M |
|
|
Jul 1, 2025 |
| Charles F. Wagner Jr |
EVP & Chief Financial Officer |
$25.8M |
-$1.65M |
-6% |
Mar 10, 2025 |
| Ourania Tatsis |
EVP, Chief Reg. & Quality Off. |
$25.6M |
-$4.27M |
-14.3% |
Mar 10, 2025 |
| Bruce I. Sachs |
Director |
$24.3M |
+$1.95M |
+8.72% |
Oct 15, 2025 |
| Carmen Bozic |
EVP and CMO |
$15.7M |
|
|
Feb 26, 2025 |
| Bastiano Sanna |
EVP, Cell & Genetic Therapies |
$13.4M |
|
|
May 5, 2023 |
| Jeffrey M. Leiden |
Executive Chairman, Director |
$10.8M |
-$32.3M |
-74.9% |
Nov 13, 2025 |
| David Altshuler |
EVP, Chief Scientific Officer |
$9.89M |
-$6.42M |
-39.4% |
May 15, 2025 |
| Edward Morrow Atkinson III |
EVP, Chief Technical Ops. Off. |
$7.32M |
-$4M |
-35.3% |
Nov 17, 2025 |
| Duncan McKechnie |
EVP, Chief Commercial Officer |
$6.97M |
|
|
Jul 1, 2025 |
| Jonathan Biller |
EVP and Chief Legal Officer |
$6.33M |
-$2.61M |
-29.2% |
Oct 1, 2025 |
| Joy Liu |
SVP, General Counsel |
$4.03M |
|
|
Aug 15, 2022 |
| Kristen Ambrose |
SVP & Chief Accounting Officer |
$3.76M |
-$1.36M |
-26.6% |
Feb 26, 2025 |
| Alan M. Garber |
Director |
$3.73M |
|
|
May 1, 2025 |
| Diana Mckenzie |
Director |
$3.59M |
|
|
May 1, 2025 |
| Terrence C. Kearney |
Director |
$3.14M |
|
|
May 1, 2024 |
| Margaret G. Mcglynn |
Director |
$2.95M |
|
|
May 1, 2023 |
| Lloyd Carney |
Director |
$2.63M |
|
|
Nov 19, 2025 |
| Suketu Upadhyay |
Director |
$2.22M |
|
|
Oct 15, 2025 |
| Sangeeta N. Bhatia |
Director |
$1.77M |
-$305K |
-14.7% |
Aug 27, 2025 |
| Yuchun Lee |
Director |
$1.23M |
|
|
May 1, 2023 |
| Nancy Thornberry |
Director |
$1.19M |
|
|
May 1, 2025 |
| Jennifer Schneider |
Director |
$832K |
|
|
May 1, 2025 |
| Michel Lagarde |
Director |
$401K |
|
|
May 1, 2025 |